CDS PM 101Alternative Names: CDS PM101
Latest Information Update: 10 May 2012
At a glance
- Originator pSivida Inc
- Class Opioid analgesics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Postoperative pain
Most Recent Events
- 31 Dec 2008 Discontinued - Phase-I for Postoperative pain in USA (unspecified route)
- 03 Jan 2006 Control Delivery Systems has been acquired by pSivida
- 14 Jun 2004 Phase-I clinical trials in Postoperative pain in USA (unspecified route)